Screening for NAFLD-related Advanced Fibrosis in High Risk Population in Diabetology.

clinical trial

Details

Instance of: clinical trial
Start time: September 2020
End time: October 2023
Country: France
Main subject: type 2 diabetes, obesity, metabolic dysfunction–associated steatotic liver disease
maximum age: 80
minimum age: 40
number of participants: 1000
research subject recruitment status: not yet recruiting
short name: NAFLD-CARE
study type: interventional study
title: Screening for NAFLD-related Advanced Fibrosis in High Risk popuLation: Optimization of the Diabetology Pathway Referral Using Combinations of Non-invAsive Biological and elastogRaphy paramEters

Nothing in the MetaHistoryBook collection references this item yet.